Altimmune (ALT) Change in Intangibles (2016 - 2021)
Altimmune (ALT) reported Change in Intangibles of $5000.0 for Q4 2021, down 87.36% year-over-year from $39571.0 in Q4 2020, and down 88.89% on a QoQ basis from $45000.0 in Q3 2021.
Altimmune (ALT) has 6 years of Change in Intangibles data on file, last reported at $5000.0 in Q4 2021.
- Quarterly Change in Intangibles fell 87.36% year-over-year to $5000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $195000.0 (up 40.83% YoY) and the FY2021 annual result came in at $195000.0, up 40.83% from the prior year.
- Change in Intangibles retreated to $5000.0 in Q4 2021 per ALT's latest filing, from $45000.0 in the prior quarter.
- Across five years, Change in Intangibles topped out at $83000.0 in Q2 2021 and bottomed at $1082.0 in Q4 2018.
- The 5-year median for Change in Intangibles is $14079.5 (2017), against an average of $22767.4.
- The widest annual swing landed in 2020, when Change in Intangibles surged 1565.45%; it then tumbled 87.36% in 2021.
- Tracing ALT's Change in Intangibles over 5 years: stood at $6252.0 in 2017, then plunged by 82.69% to $1082.0 in 2018, then jumped by 119.59% to $2376.0 in 2019, then surged by 1565.45% to $39571.0 in 2020, then plunged by 87.36% to $5000.0 in 2021.
- Per Business Quant, the three latest ALT Change in Intangibles figures stand at $5000.0 (Q4 2021), $45000.0 (Q3 2021), and $83000.0 (Q2 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,980.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Altimmune | 379.61 Mn | 379.61 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 45,000.00 |
| Sep 30, 2021 | 45,000.00 |
| Jun 30, 2021 | 83,000.00 |
| Jun 30, 2021 | 83,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Mar 31, 2021 | 62,000.00 |
| Dec 31, 2020 | 39,571.00 |
| Dec 31, 2020 | 39,571.00 |
| Sep 30, 2020 | 19,557.00 |
| Sep 30, 2020 | 19,557.00 |
| Jun 30, 2020 | 59,946.00 |
| Jun 30, 2020 | 59,946.00 |
| Mar 31, 2020 | 19,390.00 |
| Mar 31, 2020 | 19,390.00 |
| Dec 31, 2019 | 2,376.00 |
| Dec 31, 2019 | 2,376.00 |
| Sep 30, 2019 | 9,522.00 |
| Sep 30, 2019 | 9,522.00 |
| Jun 30, 2019 | 12,854.00 |
| Jun 30, 2019 | 12,854.00 |
| Mar 31, 2019 | 3,020.00 |
| Mar 31, 2019 | 3,020.00 |
| Dec 31, 2018 | 1,082.00 |
| Dec 31, 2018 | 1,082.00 |
| Sep 30, 2018 | 11,640.00 |
| Sep 30, 2018 | 11,640.00 |
| Jun 30, 2018 | 12,677.00 |
| Jun 30, 2018 | 12,677.00 |
| Mar 31, 2018 | 14,828.00 |
| Mar 31, 2018 | 14,828.00 |
| Dec 31, 2017 | 6,252.00 |
| Dec 31, 2017 | 6,252.00 |
| Sep 30, 2017 | 17,008.00 |
| Sep 30, 2017 | 17,008.00 |
| Jun 30, 2017 | 13,331.00 |
| Jun 30, 2017 | 13,331.00 |
| Mar 31, 2017 | 17,295.00 |
| Mar 31, 2017 | 17,295.00 |
| Dec 31, 2016 | 29,308.00 |
| Dec 31, 2016 | 29,308.00 |
| Sep 30, 2016 | 18,933.00 |
| Sep 30, 2016 | 18,933.00 |